Novartis Standing In Patent Suit V. Teva Still Unclear
Efforts by drugmaker Teva Pharmaceuticals USA Inc. to dismiss rival Novartis Pharmaceuticals Corp.'s patent infringement suit over generic herpes medications have been stymied in federal court following a judge's ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article